Based in part on NIGMS-supported research on how gene variation affects a person’s response to medicines, the U.S. Food and Drug Administration has modified the prescribing instructions for warfarin (Coumadin), a widely used blood thinner.
B. Braun Medical Inc., Bethlehem, PA, announced on July 30, 2007 a voluntary nationwide recall of Normal Saline Flush syringes with lot numbers ending in “SFR” due to an increase in customer complaints for particulate matter in the saline.
While obesity has been shown to contribute to high blood pressure, heart disease and diabetes, being overweight in old age does not lead to memory problems, according to a study published September 19, 2007, in the online edition of Neurology®, the medical journal of the American Academy of Neurology.
A scientist at Leeds whose research is challenging conventional thinking on how the cholesterol-reducing drugs statins benefit cardiac patients, has secured funding to further investigate her findings.
A new study led by investigators from the University of Pittsburgh School of Medicine demonstrates that the process of necrosis, long thought to be a chaotic, irreversible pathway to cell death, may actually be triggered as part of a regulated response to stress by a powerful protein, SRP-6, that can potentially halt necrosis in its path.
Failing to pay attention to your vascular health could lead to potentially life-threatening conditions, including “silent” blood clots that travel through the bloodstream into the heart or lungs.
New research, including two studies presented this week at the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD), further support the cardiovascular safety of ACTOS (pioglitazone HCI) and its benefits regarding improved blood glucose and blood lipid levels for patients with type 2 diabetes.
An analysis of previously published studies suggests that there are approximately linear relationships of apolipoprotein E genotypes with lipid levels and with coronary risk, according to a review article in the Sept. 19 issue of JAMA.
Despite the huge publicity generated by a 2002 study on the potential dangers of hormone therapy for postmenopausal women, new research from the Stanford University School of Medicine found that only 29 percent of women surveyed knew about the study two years later.
The U.S. Food and Drug Administration has cleared for marketing the first rapid test to detect bacterial contamination in blood platelets prior to transfusion.